The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena ...
The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena ...
The FDA (Food and Drug Administration) recently sent a letter expressing its dissatisfaction with a TV commercial featuring ...
In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...
The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena ...
A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure ...
Atlanta Black Star News on MSN4d
'Aint She Rich Enuf?': Serena Williams Under Fire as the FDA Steps In Following 'Misleading' Commercial for Migraine Medicine MakerA migraine medicine once-endorsed by Serena Williams has come under fire amid claims advertisements oversold it’s usefulness.
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...
Ubrelvy is taken as a 50 or 100 mg pill ... which was published in the journal Neurology. Despite this, the FDA letter stated, the advertisement made it seem like the drug will work for ...
In the FDA's letter, the agency says the advertisements overstate the benefits of Ubrelvy. The FDA says that the treatment appears to show Williams' migraine instantly going away when in reality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback